Universität zu Köln

Benza, Raymond, Frost, Adaani, Farber, Harrison, Ghofrani, Hossein Ardeschir, Gomez-Sanchez, Miguel, Langleben, David, Rosenkranz, Stephan, Busse, Dennis, Meier, Christian, Nikkho, Sylvia and Hoeper, Marius (2015). Application of REVEAL Risk Score to Patients With PAH Receiving Riociguat in the PATENT-2 Study. Chest, 148 (4). GLENVIEW: AMER COLL CHEST PHYSICIANS. ISSN 0012-3692

Benza, Raymond, Frost, Adaani, Farber, Harrison, Ghofrani, Hossein-Ardeschir, Gomez Sanchez, Miguel Angel, Langleben, David, Rosenkranz, Stephan, Busse, Dennis, Meier, Christian, Nikkho, Sylvia and Hoeper, Marius (2015). Calculation of REVEAL scores for patients with PAH receiving riociguat in the PATENT-2 study. Eur. Resp. J., 46. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003

Benza, Raymond L., Corris, Paul A., Klinger, James R., Langleben, David, Naeije, Robert, Simonneau, Gerald, Ghofrani, Hossein-Ardeschir, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Scelsi, Laura, Thenappan, Thenappan ORCID: 0000-0002-6210-0467, Raina, Amresh, Meier, Christian, Busse, Dennis and Hoeper, Marius M. (2020). Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE. Int. J. Cardiol., 317. S. 188 - 193. CLARE: ELSEVIER IRELAND LTD. ISSN 1874-1754

Benza, Raymond L., Farber, Harrison W., Frost, Adaani, Ghofrani, Hossein-Ardeschir, Gomez-Sanchez, Miguel A., Langleben, David, Rosenkranz, Stephan, Busse, Dennis, Meier, Christian, Nikkho, Sylvia and Hoeper, Marius M. (2018). REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival. J. Heart Lung Transplant., 37 (4). S. 513 - 520. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117

Ghofrani, Hossein-Ardeschir, Gruenig, Ekkehard, Jansa, Pavel ORCID: 0000-0002-3711-7064, Langleben, David, Rosenkranz, Stephan, Preston, Ioana R., Rahaghi, Franck, Sood, Namita, Busse, Dennis, Meier, Christian and Humbert, Marc (2020). Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies). Pulm. Circ., 10 (3). THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2045-8940

Hoeper, Marius M., Simonneau, Gerald, Corris, Paul A., Ghofrani, Hossein-Ardeschir, Klinger, James R., Langleben, David, Naeije, Robert, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Scelsi, Laura ORCID: 0000-0001-9409-691X, Gruenig, Ekkehard, Vizza, Carmine Dario, Chang, MiKyung, Colorado, Pablo, Meier, Christian, Busse, Dennis and Benza, Raymond L. (2017). RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. Eur. Resp. J., 50 (3). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003

Simonneau, Gerald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Rosenkranz, Stephan, Gruenig, Ekkehard, White, Jim, McLaughlin, Vallerie V., Langleben, David, Meier, Christian, Busse, Dennis, Kleinjung, Frank and Benza, Raymond L. (2020). Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study. Pulm. Circ., 10 (4). THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2045-8940